PubRank

Brian Becknell

Author PubWeight™ 52.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med 2006 3.29
2 Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations. J Clin Invest 2006 3.27
3 A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 2005 3.14
4 Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 2010 2.67
5 Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat Genet 2005 2.63
6 Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity 2006 2.56
7 The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody. Blood 2010 2.41
8 Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood 2009 2.18
9 The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood 2005 1.73
10 Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood 2004 1.73
11 Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia. Cancer Res 2005 1.69
12 Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Blood 2004 1.39
13 IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins. J Immunol 2007 1.23
14 A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies. Genomics 2004 1.20
15 Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Proc Natl Acad Sci U S A 2007 1.19
16 The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse. J Clin Invest 2003 1.17
17 The PP2A inhibitor SET regulates natural killer cell IFN-gamma production. J Exp Med 2007 1.15
18 Deletion of Frs2alpha from the ureteric epithelium causes renal hypoplasia. Am J Physiol Renal Physiol 2009 1.12
19 PRDM1/Blimp-1 controls effector cytokine production in human NK cells. J Immunol 2010 1.11
20 The innate immune response during urinary tract infection and pyelonephritis. Pediatr Nephrol 2013 1.10
21 Human alpha defensin 5 expression in the human kidney and urinary tract. PLoS One 2012 1.08
22 Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420. Clin Cancer Res 2002 1.00
23 STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo. Eur J Immunol 2006 0.96
24 Transcriptional control of human T-BET expression: the role of Sp1. Eur J Immunol 2007 0.96
25 Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells. Blood 2008 0.94
26 Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity. Blood 2006 0.93
27 Ultrasound imaging of the murine kidney. Methods Mol Biol 2012 0.89
28 Modulation of SOCS protein expression influences the interferon responsiveness of human melanoma cells. BMC Cancer 2010 0.88
29 New directions in natural killer cell-based immunotherapy of human cancer. Expert Opin Biol Ther 2003 0.87
30 Responsiveness of naive CD4 T cells to polarizing cytokine determines the ratio of Th1 and Th2 cell differentiation. J Immunol 2006 0.85
31 A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia. Leuk Res 2009 0.84
32 Trends in pediatric urolithiasis: patient characteristics, associated diagnoses, and financial burden. Pediatr Nephrol 2014 0.82
33 The demographics and costs of inpatient vesicoureteral reflux management in the USA. Pediatr Nephrol 2011 0.82
34 Urinary diversion via cutaneous vesicostomy in the megabladder mouse. Methods Mol Biol 2012 0.80
35 Bacterial differentiation, development, and disease: mechanisms for survival. FEMS Microbiol Lett 2014 0.80
36 Crucial roles of the protein kinases MK2 and MK3 in a mouse model of glomerulonephritis. PLoS One 2013 0.77
37 Cancer T cell therapy expands. Nat Med 2003 0.75